ATE86498T1 - Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten. - Google Patents

Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.

Info

Publication number
ATE86498T1
ATE86498T1 AT88909248T AT88909248T ATE86498T1 AT E86498 T1 ATE86498 T1 AT E86498T1 AT 88909248 T AT88909248 T AT 88909248T AT 88909248 T AT88909248 T AT 88909248T AT E86498 T1 ATE86498 T1 AT E86498T1
Authority
AT
Austria
Prior art keywords
low density
density lipoproteins
reduction
biological fluids
ldl
Prior art date
Application number
AT88909248T
Other languages
English (en)
Inventor
Robert S Lees
Robert S Langer Jr
Claudy J P Mullon
Hugh D Conlon
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22283752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE86498(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE86498T1 publication Critical patent/ATE86498T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1678—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes intracorporal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0456—Lipoprotein
    • A61M2202/046—Low-density lipoprotein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • External Artificial Organs (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT88909248T 1987-09-25 1988-09-20 Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten. ATE86498T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/101,262 US5232696A (en) 1987-09-25 1987-09-25 Reduction of low density lipoproteins in biological fluids
EP88909248A EP0382772B1 (de) 1987-09-25 1988-09-20 Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen flüssigkeiten
PCT/US1988/003245 WO1989002748A1 (en) 1987-09-25 1988-09-20 Reduction of low density lipoproteins in biological fluids

Publications (1)

Publication Number Publication Date
ATE86498T1 true ATE86498T1 (de) 1993-03-15

Family

ID=22283752

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88909248T ATE86498T1 (de) 1987-09-25 1988-09-20 Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.

Country Status (7)

Country Link
US (1) US5232696A (de)
EP (1) EP0382772B1 (de)
JP (1) JP2761013B2 (de)
AT (1) ATE86498T1 (de)
CA (1) CA1336814C (de)
DE (1) DE3879220T2 (de)
WO (1) WO1989002748A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK425989D0 (da) * 1989-08-30 1989-08-30 Novo Nordisk As Hydrolyse af phospholipider
US5178864A (en) * 1990-08-14 1993-01-12 Mit Lipoprotein removal by soluble enzymes
RU2143267C1 (ru) * 1998-01-05 1999-12-27 Государственное унитарное предприятие "Иммунопрепарат" Способ очистки белков плазмы от липопротеинов (его варианты)
EP1989144A4 (de) 2006-02-02 2014-01-29 Innovative Bio Therapies Extrakorporale zellbasierte therapeutische vorrichtung und freisetzungssystem
WO2010071692A2 (en) * 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
WO2012145428A2 (en) * 2011-04-21 2012-10-26 Washington University Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid
US20170044516A1 (en) 2015-08-11 2017-02-16 Industrial Technology Research Institute Biochemistry reactive material and device for eliminating electronegative low-density lipoprotein (ldl) and method for treating blood or plasma ex vivo to eliminate electronegative low-density lipoprotein therein
TWI580782B (zh) * 2015-08-11 2017-05-01 財團法人工業技術研究院 去除陰電性低密度脂蛋白之生化反應材料與裝置以及體外處理血液或血漿以去除其中陰電性低密度脂蛋白的方法
US12011691B2 (en) 2020-08-19 2024-06-18 Shanghai Xinguang Bio-Pharmaceutical Ltd. Fluid treatment method, cycle treatment device and system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6622M (de) * 1967-09-12 1969-01-13
US3959467A (en) * 1973-02-06 1976-05-25 Amano Pharmaceutical Co., Ltd. Lipid metabolism improving and anti-atheromatic agent
US3963613A (en) * 1973-12-29 1976-06-15 Tanabe Seiyaku Co., Ltd. Blood purification means
CA1259915A (en) * 1985-10-09 1989-09-26 Sailen S. Mookerjea Means to reduce plasma cholesterol

Also Published As

Publication number Publication date
DE3879220D1 (de) 1993-04-15
WO1989002748A1 (en) 1989-04-06
CA1336814C (en) 1995-08-29
EP0382772A1 (de) 1990-08-22
DE3879220T2 (de) 1993-10-07
JP2761013B2 (ja) 1998-06-04
US5232696A (en) 1993-08-03
JPH03502054A (ja) 1991-05-16
EP0382772B1 (de) 1993-03-10

Similar Documents

Publication Publication Date Title
US5236413B1 (en) Method and apparatus for inducing the permeation of medication into internal tissue
ATE291939T1 (de) Methode und vorrichtung zur aufzeichnung des zustandes eines blutgefässzugangs
ATE65703T1 (de) Anordnung zur beseitigung von aktiven mitteln, oertlich verwendet gegen feste tumoren.
DE69633411D1 (de) Vorrichtung zur umgehung von arteriellen verengungen und/oder zur ausführung anderer transvaskularer eingriffe
ATE63826T1 (de) Pumpenkoerper zum anschluss einer bestrahlungskammer an ein system zur behandlung eines patienten durch photoaktivierung.
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
ATE57843T1 (de) Geraet zur behandlung des menschlichen koerpers mit radioaktiven stoffen.
HUP9802264A2 (hu) A vér oxigénszintjének mérésére szolgáló rendszer
SE9100142D0 (sv) A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose
ATE86498T1 (de) Verminderung des gehaltes an lipoproteine mit geringer dichte in biologischen fluessigkeiten.
NO20020056D0 (no) Fremgangsmåte og system for anvendelse ved behandling av en pasient med et hvilket som helst medikament for å optimalisereterapien og forhindre en negativ medikamentrespons
ATE63225T1 (de) Kraftfrei einzufuehrender anschluss fuer ein system zur behandlung eines patienten durch photoaktivierung.
UA10842C2 (uk) Спосіб лікуваhhя хроhічhого та хроhічhого рецидивуючого паhкреатитів
HUP9801606A2 (hu) Folyékony fluor-szénhidrogének alkalmazása tödőszövet és más szövetek szaporodásának meggyorsítására
SE9101341D0 (sv) New medicinal use
BRAGIN Effects of prolonged exposure to acetic acid vapors on acid-base balance in humans(Abstract Only)
Lang et al. Verapamil therapy and blood glucose concentration
UA30631A (uk) Спосіб лікування надмірної ваги
UA42132A (uk) Спосіб лікування захворювань системи травлення
Onorato Invasive amebiasis
UA42123A (uk) Спосіб лікування захворювань нейроендокринної системи
RU1799271C (ru) Способ проведени гемосорбции
林石化 et al. Aeromonas Hydrophila Septicemia with Myonecrosis and Gas Gangrene in a Patient Receiving Hemodialysis
McGregor Vascular and pathological aspects of surgical conservation of the mandible in treatment of intra-oral cancer
BLACHLY Drug Dosage in ECT

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee